(CAMT) Camtek - Ratings and Ratios
Exchange: NASDAQ • Country: Israel • Currency: USD • Type: Common Stock • ISIN: IL0010952641
CAMT: Inspection, Metrology, Equipment, Semiconductor, Manufacturing
Camtek Ltd. (NASDAQ: CAMT) is a pivotal player in the semiconductor industry, specializing in the development, manufacturing, and distribution of advanced inspection and metrology equipment. Their tools are essential for ensuring the quality and precision required in the production of semiconductors, particularly as the complexity of chips increases. Camteks solutions are integral to maintaining high standards in a sector where even minor defects can have significant implications.
The companys product portfolio includes the Eagle series, such as Eagle-i for 2D inspection and Eagle-AP for advanced packaging, which combines 2D and 3D capabilities. The Golden Eagle is tailored for fanout wafer-level packaging. Beyond these, Camtek offers a range of MicroProf tools, each designed for specific applications like wafer metrology and surface measurement. These tools utilize cutting-edge technologies, including deep learning for defect classification, enhancing efficiency and reducing manual intervention.
Financially, Camtek boasts a market capitalization of approximately $3.9 billion, reflecting its significant presence in the industry. With a P/E ratio of 39.60 and a forward P/E of 23.36, the company indicates strong growth prospects. The P/S ratio of 10.62 underscores its robust revenue generation relative to its market value. These metrics are pivotal for investors assessing potential returns in the dynamic semiconductor sector.
Camtek serves a diverse customer base, including semiconductor manufacturers, outsourced semiconductor assembly and test companies (OSATs), integrated device manufacturers (IDMs), and wafer-level packaging subcontractors. Founded in 1987 and headquartered in Migdal Haemek, Israel, Camtek is strategically positioned to support the global semiconductor industrys evolving needs. Their expertise and innovative solutions make them a key partner for companies navigating the complexities of advanced semiconductor manufacturing.
Additional Sources for CAMT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CAMT Stock Overview
Market Cap in USD | 3,631m |
Sector | Technology |
Industry | Semiconductor Equipment & Materials |
GiC Sub-Industry | Semiconductor Materials & Equipment |
IPO / Inception | 2000-07-28 |
CAMT Stock Ratings
Growth 5y | 68.4% |
Fundamental | 22.7% |
Dividend | 31.7% |
Rel. Strength Industry | -14.9 |
Analysts | 4.75/5 |
Fair Price Momentum | 83.31 USD |
Fair Price DCF | 9.82 USD |
CAMT Dividends
Dividend Yield 12m | 1.61% |
Yield on Cost 5y | 12.24% |
Annual Growth 5y | % |
Payout Consistency | 43.9% |
CAMT Growth Ratios
Growth Correlation 3m | 70.8% |
Growth Correlation 12m | -8.6% |
Growth Correlation 5y | 80.4% |
CAGR 5y | 47.60% |
CAGR/Max DD 5y | 0.85 |
Sharpe Ratio 12m | 0.11 |
Alpha | -49.29 |
Beta | 2.50 |
Volatility | 60.81% |
Current Volume | 688.9k |
Average Volume 20d | 675.1k |
As of February 22, 2025, the stock is trading at USD 76.39 with a total of 688,948 shares traded.
Over the past week, the price has changed by -12.01%, over one month by -28.70%, over three months by +1.17% and over the past year by +1.05%.
Neither. Based on ValueRay Fundamental Analyses, Camtek is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 22.67 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CAMT as of February 2025 is 83.31. This means that CAMT is currently overvalued and has a potential downside of 9.06%.
Camtek has received a consensus analysts rating of 4.75. Therefor, it is recommend to buy CAMT.
- Strong Buy: 6
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CAMT Camtek will be worth about 100 in February 2026. The stock is currently trading at 76.39. This means that the stock has a potential upside of +30.87%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 110 | 44% |
Analysts Target Price | 110.6 | 44.8% |
ValueRay Target Price | 100 | 30.9% |